...
首页> 外文期刊>Hepatology: Official Journal of the American Association for the Study of Liver Diseases >Endoplasmic Reticulum Stress Causes Liver Cancer Cells to Release Exosomal miR-23a-3p and Up-regulate Programmed Death Ligand 1 Expression in Macrophages
【24h】

Endoplasmic Reticulum Stress Causes Liver Cancer Cells to Release Exosomal miR-23a-3p and Up-regulate Programmed Death Ligand 1 Expression in Macrophages

机译:内质网胁迫导致肝癌细胞释放外泌体miR-23a-3p和上调程序的死亡配体1在巨噬细胞中的表达

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Endoplasmic reticulum (ER) stress promotes tumor cell escape from immunosurveillance. However, the underlying mechanisms remain unknown. We hypothesized that ER stress induces hepatocellular carcinoma (HCC) cells to release exosomes, which attenuate antitumor immunity by modulating the expression of programmed death ligand 1 (PD-L1) in macrophages. In this study, we demonstrated that expression of several ER stress markers (glucose-regulated protein 78, activating transcription factor 6, protein kinase R-like ER kinase, and inositol-requiring enzyme 1 alpha) was up-regulated in HCC tissues and negatively correlated with the overall survival and clinicopathological scores in patients with HCC. Expression of ER stress-related proteins positively correlated with CD68(+) macrophage recruitment and PD-L1 expression in HCC tissues. High-throughput sequencing analysis identified miR-23a-3p as one of the most abundant microRNAs in exosomes derived from tunicamycin (TM)-treated HCC cells (Exo-TMs). miR-23a-3p levels in HCC tissues negatively correlated with overall survival. Treatment with Exo-TMs up-regulated the expression of PD-L1 in macrophages in vitro and in vivo. Bioinformatics analysis suggests that miR-23a-3p regulates PD-L1 expression through the phosphatase and tensin homolog (PTEN)-phosphatidylinositol 3-kinase-protein kinase B (AKT) pathway. This notion was confirmed by in vitro transfection and coculture experiments, which revealed that miR-23a-3p inhibited PTEN expression and subsequently elevated phosphorylated AKT and PD-L1 expression in macrophages. Finally, coculture of T cells with Exo-TM-stimulated macrophages decreased CD8(+) T-cell ratio and interleukin-2 production but increased T-cell apoptosis in vitro. Conclusion: ER-stressed HCC cells release exosomes to up-regulate PD-L1 expression in macrophages, which subsequently inhibits T-cell function through an exosome miR-23a-PTEN-AKT pathway. Our findings provide insight into the mechanism how tumor cells escape from antitumor immunity.
机译:内质网(ER)应力从免疫监视促进肿瘤细胞逃逸。但是,潜在机制仍然未知。我们假设,ER应激诱导肝细胞癌(HCC)细胞释放外来体,其通过调节巨噬细胞中程序性死亡配体1(PD-L1)的表达减弱抗肿瘤免疫性。在这项研究中,我们证明了几个ER应激标记物(葡萄糖调节蛋白78,激活转录因子6,蛋白激酶R-像ER激酶和肌醇需要酶1个阿尔法)上调HCC组织和带负该表达与肝癌患者的总生存期和临床分数相关。与CD68(+)巨噬细胞募集和PD-L1表达在肝癌组织正相关ER应激相关的蛋白质的表达。高通量测序分析鉴定的miR-23A-3P为从衣霉素(TM)治疗肝癌细胞(出-TMS)衍生的外来体中最丰富的微小RNA中的一个。在肝癌组织中的miR-23A-3P水平与总生存率呈负相关。与外切-TMS治疗上调巨噬细胞中在体外和体内PD-L1的表达。生物信息学分析表明了miR-23A-3P通过磷酸酶和张力蛋白同源物(PTEN)-phosphatidylinositol 3-激酶的蛋白激酶B(AKT)途径调节PD-L1表达。这个概念由体外转染和共培养实验中,其揭示了miR-23A-3P抑制PTEN表达和随后高架磷酸化AKT和PD-L1在巨噬细胞中表达的证实。最后,用外切TM-刺激巨噬细胞的T细胞共培养降低CD8(+)T细胞比率和白细胞介素-2生产,但在体外增加T细胞的细胞凋亡。结论:ER-强调HCC细胞释放外来体上调巨噬细胞中PD-L1表达,其随后通过抑制外来体的miR-23A-PTEN-AKT途径的T细胞的功能。我们的发现提供洞察机制肿瘤细胞的抗肿瘤免疫逃逸如何。

著录项

  • 来源
  • 作者单位

    Anhui Med Univ Affiliated Hosp 1 Dept Oncol 218 Jixi Rd Hefei 230022 Anhui Peoples R China;

    Anhui Med Univ Affiliated Hosp 1 Dept Oncol 218 Jixi Rd Hefei 230022 Anhui Peoples R China;

    Anhui Med Univ Affiliated Hosp 1 Dept Oncol 218 Jixi Rd Hefei 230022 Anhui Peoples R China;

    Anhui Med Univ Affiliated Hosp 1 Dept Oncol 218 Jixi Rd Hefei 230022 Anhui Peoples R China;

    NIAAA Lab Liver Dis NIH Bethesda MD USA;

    NIAAA Lab Liver Dis NIH Bethesda MD USA;

    Anhui Med Univ Affiliated Hosp 1 Dept Oncol 218 Jixi Rd Hefei 230022 Anhui Peoples R China;

    Anhui Med Univ Affiliated Hosp 1 Dept Oncol 218 Jixi Rd Hefei 230022 Anhui Peoples R China;

    Anhui Med Univ Affiliated Hosp 1 Dept Oncol 218 Jixi Rd Hefei 230022 Anhui Peoples R China;

    Anhui Med Univ Affiliated Hosp 1 Dept Oncol 218 Jixi Rd Hefei 230022 Anhui Peoples R China;

    Anhui Med Univ Affiliated Hosp 1 Dept Oncol 218 Jixi Rd Hefei 230022 Anhui Peoples R China;

    NIAAA Lab Liver Dis NIH Bethesda MD USA;

    Anhui Med Univ Inst Clin Pharmacol Hefei Anhui Peoples R China;

    Anhui Med Univ Affiliated Hosp 1 Dept Oncol 218 Jixi Rd Hefei 230022 Anhui Peoples R China;

    Anhui Med Univ Affiliated Hosp 1 Dept Oncol 218 Jixi Rd Hefei 230022 Anhui Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 消化系及腹部疾病;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号